novo nordisk glp-1 Forms Partnership with Hims & Hers Ozempic maker Novo Nordisk is
Description
Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore
Achieve effective weight loss and appetite control with GLP-1 injections designed for lasting results
A mitochondrial switch ("SLC25A45") controls whether mitochondria burn fat or carbohydrate, and removing it (in mice) makes GLP-1 drugs stop working for fat loss entirely
Id also raise the question of whether the incretins and other GLP-1 agonists will ever be free of adverse GI symptoms, as it seems intrinsic to the drugs mechanism.
